Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Depreciation & Amortization (CF) (2022 - 2024)

Historic Depreciation & Amortization (CF) for Pasithea Therapeutics (KTTA) over the last 3 years, with Q4 2024 value amounting to $4717.0.

  • Pasithea Therapeutics' Depreciation & Amortization (CF) rose 79.06% to $4717.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $19434.0, marking a year-over-year increase of 625.48%. This contributed to the annual value of $18865.0 for FY2024, which is 314.38% up from last year.
  • Pasithea Therapeutics' Depreciation & Amortization (CF) amounted to $4717.0 in Q4 2024, which was up 79.06% from $5000.0 recorded in Q3 2024.
  • Pasithea Therapeutics' Depreciation & Amortization (CF)'s 5-year high stood at $16670.0 during Q3 2022, with a 5-year trough of $4138.0 in Q4 2022.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $4717.0 (2024), whereas its average is $6194.4.
  • Within the past 5 years, the most significant YoY rise in Pasithea Therapeutics' Depreciation & Amortization (CF) was 1309.81% (2023), while the steepest drop was 7171.57% (2023).
  • Over the past 3 years, Pasithea Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $4138.0 in 2022, then increased by 13.1% to $4680.0 in 2023, then increased by 0.79% to $4717.0 in 2024.
  • Its Depreciation & Amortization (CF) stands at $4717.0 for Q4 2024, versus $5000.0 for Q3 2024 and $5000.0 for Q2 2024.